| Texto completo | |
| Autor(es): |
R. Ávila
[1]
;
C.M.C. Bottino
[2]
;
I.A.M. Carvalho
[3]
;
C.B. Santos
[4]
;
C. Seral
[5]
;
E.C. Miotto
[6]
Número total de Autores: 6
|
| Afiliação do(s) autor(es): | [1] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
[2] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
[3] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
[4] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
[5] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
[6] Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria - Brasil
Número total de Afiliações: 6
|
| Tipo de documento: | Artigo Científico |
| Fonte: | Brazilian Journal of Medical and Biological Research; v. 37, n. 11, p. 1721-1729, 2004-11-00. |
| Resumo | |
Patients with Alzheimer's disease (AD) gradually lose their cognitive competence, particularly memory, and the ability to perform daily life tasks. Neuropsychological rehabilitation is used to improve cognitive functions by facilitating memory performance through the use of external aids and internal strategies. The effect of neuropsychological rehabilitation through memory training - motor movements, verbal association, and categorization - and activities of daily living (ADL) training was tested in a sample of 5 elderly out-patients (mean age: 77.4 ± 2.88 years), with mild AD (Mini-Mental State Examination score: 22.20 ± 2.17) and their caregivers. All patients had been taking rivastigmine (6-12 mg/day) for at least 3 months before being assigned to the rehabilitation sessions, and they continued to take the medication during the whole program. Just before and after the 14-week neuropsychological rehabilitation program all patients were assessed by interviewers that did not participate in the cognitive training, using the Mini-Mental State Examination, Montgomery-Alsberg Depression Rating Scale, Hamilton Anxiety Scale, Interview to Determine Deterioration in Functioning in Dementia, Functional Test, Memory Questionnaire of Daily Living for patient and caregiver, Quality of Life Questionnaire for patient and caregiver, and a neuropsychological battery. The results showed a statistically significant improvement in ADL measured by Functional Test (P = 0.04), and only a small improvement in memory and psychiatric symptoms. Our results support the view that weekly stimulation of memory and training of ADL is believed to be of great value in AD treatment, not only delaying the progress of the disease, but also improving some cognitive functions and ADL, even though AD is a progressively degenerative disease. (AU) | |
| Processo FAPESP: | 01/08189-8 - Reabilitação neuropsicológica nos processos mnésticos de pacientes com Doença de Alzheimer |
| Beneficiário: | Renata Avila Thomas |
| Modalidade de apoio: | Bolsas no Brasil - Mestrado |